Sponsor:
General Oncology, Inc.
Code:
NCT04150042
Conditions
Pancreatic Adenocarcinoma Metastatic
BRCA1 Mutation
BRCA2 Mutation
Pancreatic Acinar Cell Carcinoma
Pancreatic Ductal Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Melphalan
BCNU
Vitamin B12B
Vitamin C
Autologous Hematopoietic Stem Cells
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-17. This information was provided to ClinicalTrials.gov by General Oncology, Inc. on 2026-01-29.